A randomized 3-way crossover study indicates that high-protein feeding induces de novo lipogenesis in healthy humans
File(s)
Author(s)
Type
Journal Article
Abstract
BACKGROUND. Dietary changes have led to the growing prevalence of type 2 diabetes and
nonalcoholic fatty liver disease. A hallmark of both disorders is hepatic lipid accumulation, derived
in part from increased de novo lipogenesis. Despite the popularity of high-protein diets for weight
loss, the effect of dietary protein on de novo lipogenesis is poorly studied. We aimed to characterize
the effect of dietary protein on de novo lipid synthesis.
METHODS. We use a 3-way crossover interventional study in healthy males to determine the
effect of high-protein feeding on de novo lipogenesis, combined with in vitro models to determine
the lipogenic effects of specific amino acids. The primary outcome was a change in de novo
lipogenesis–associated triglycerides in response to protein feeding.
RESULTS. We demonstrate that high-protein feeding, rich in glutamate, increases de novo
lipogenesis–associated triglycerides in plasma (1.5-fold compared with control; P < 0.0001) and
liver-derived very low-density lipoprotein particles (1.8-fold; P < 0.0001) in samples from human
subjects (n = 9 per group). In hepatocytes, we show that glutamate-derived carbon is incorporated
into triglycerides via palmitate. In addition, supplementation with glutamate, glutamine, and
leucine, but not lysine, increased triglyceride synthesis and decreased glucose uptake. Glutamate,
glutamine, and leucine increased activation of protein kinase B, suggesting that induction of de
novo lipogenesis occurs via the insulin signaling cascade.
CONCLUSION. These findings provide mechanistic insight into how select amino acids induce de
novo lipogenesis and insulin resistance, suggesting that high-protein feeding to tackle diabetes and
obesity requires greater consideration.
FUNDING. The research was supported by UK Medical Research Council grants MR/P011705/1, MC_
UP_A090_1006 and MR/P01836X/1. JLG is supported by the Imperial Biomedical Research Centre,
National Institute for Health Research (NIHR).
nonalcoholic fatty liver disease. A hallmark of both disorders is hepatic lipid accumulation, derived
in part from increased de novo lipogenesis. Despite the popularity of high-protein diets for weight
loss, the effect of dietary protein on de novo lipogenesis is poorly studied. We aimed to characterize
the effect of dietary protein on de novo lipid synthesis.
METHODS. We use a 3-way crossover interventional study in healthy males to determine the
effect of high-protein feeding on de novo lipogenesis, combined with in vitro models to determine
the lipogenic effects of specific amino acids. The primary outcome was a change in de novo
lipogenesis–associated triglycerides in response to protein feeding.
RESULTS. We demonstrate that high-protein feeding, rich in glutamate, increases de novo
lipogenesis–associated triglycerides in plasma (1.5-fold compared with control; P < 0.0001) and
liver-derived very low-density lipoprotein particles (1.8-fold; P < 0.0001) in samples from human
subjects (n = 9 per group). In hepatocytes, we show that glutamate-derived carbon is incorporated
into triglycerides via palmitate. In addition, supplementation with glutamate, glutamine, and
leucine, but not lysine, increased triglyceride synthesis and decreased glucose uptake. Glutamate,
glutamine, and leucine increased activation of protein kinase B, suggesting that induction of de
novo lipogenesis occurs via the insulin signaling cascade.
CONCLUSION. These findings provide mechanistic insight into how select amino acids induce de
novo lipogenesis and insulin resistance, suggesting that high-protein feeding to tackle diabetes and
obesity requires greater consideration.
FUNDING. The research was supported by UK Medical Research Council grants MR/P011705/1, MC_
UP_A090_1006 and MR/P01836X/1. JLG is supported by the Imperial Biomedical Research Centre,
National Institute for Health Research (NIHR).
Date Issued
2019-06-20
Date Acceptance
2019-05-08
Citation
JCI insight, 2019, 4 (12), pp.1-21
ISSN
2379-3708
Publisher
JCI Insight
Start Page
1
End Page
21
Journal / Book Title
JCI insight
Volume
4
Issue
12
Copyright Statement
© 2019, Charidemou
et al. This is an open access article
published under the terms of the
Creative Commons Attribution 4.0
International License (https://creativecommons.org/licenses/by/4.0/).
et al. This is an open access article
published under the terms of the
Creative Commons Attribution 4.0
International License (https://creativecommons.org/licenses/by/4.0/).
Identifier
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000472162400003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
Subjects
Science & Technology
Life Sciences & Biomedicine
Medicine, Research & Experimental
Research & Experimental Medicine
ATP-CITRATE LYASE
INSULIN-RESISTANCE
HIGH-CARBOHYDRATE
FATTY-ACIDS
AMINO-ACID
HEPATIC STEATOSIS
SPECTROMETRY DATA
APOC-III
LIVER
FOXO1
Publication Status
Published
Article Number
ARTN e124819
Date Publish Online
2019-05-23